Literature DB >> 8134193

The effect of inhaled nitric oxide on the pulmonary circulation of the neonatal pig.

L D Nelin1, J Moshin, C J Thomas, P Sasidharan, C A Dawson.   

Abstract

To study the pulmonary vasodilator selectivity of low levels of inhaled nitric oxide (NO) in a model of neonatal pulmonary hypertension, we sequentially exposed anesthetized, spontaneously breathing neonatal pigs to each of four different inspired gas mixtures: room air, room air with 25 parts per million NO, hypoxia (14% O2 in N2), and hypoxia with 25 parts per million NO. The room air, room air with NO, hypoxia, and hypoxia with NO exposures were of 15-min duration. The following measurements were made: mean systemic arterial, mean pulmonary arterial, and wedge pressures; thermodilution cardiac output; esophageal pressure; tracheal flow; and arterial PO2, PCO2, pH, hemoglobin, and methemoglobin. Inhalation of NO decreased pulmonary arterial pressure in both room air and hypoxia conditions (mean pulmonary arterial pressure 16 +/- 1 torr room air, 13 +/- 1 torr room air with NO, p < 0.005; and mean pulmonary arterial pressure 21 +/- 2 torr hypoxia, 14 +/- 1 torr hypoxia with NO, p < 0.005). NO had no significant effect on systemic arterial pressure, cardiac output, dynamic lung compliance, pulmonary resistance, or the measured blood variables during either control or hypoxic conditions. The results indicate that inhaled NO was a selective pulmonary vasodilator that could effectively reverse acute hypoxic pulmonary vasoconstriction. The normoxic vasodilation produced by NO inhalation also indicates the existence of basal vasomotor tone in the anesthetized, spontaneously breathing neonatal pig. The short-term exposures used produced no detectable manifestations of toxic side effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8134193     DOI: 10.1203/00006450-199401000-00006

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Nitric oxide and exercise in the horse.

Authors:  P C Mills; D J Marlin; E Demoncheaux; C Scott; I Casas; N C Smith; T Higenbottam
Journal:  J Physiol       Date:  1996-09-15       Impact factor: 5.182

Review 2.  The pharmacology of inhaled nitric oxide.

Authors:  A D Edwards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

3.  Arginase I gene single-nucleotide polymorphism is associated with decreased risk of pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  J K Trittmann; L D Nelin; E J Zmuda; J M Gastier-Foster; B Chen; C H Backes; J Frick; P Vaynshtok; V J Vieland; M A Klebanoff
Journal:  Acta Paediatr       Date:  2014-07-06       Impact factor: 2.299

4.  A single nucleotide polymorphism in the dimethylarginine dimethylaminohydrolase gene is associated with lower risk of pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Jennifer K Trittmann; Julie M Gastier-Foster; Erik J Zmuda; Jessica Frick; Lynette K Rogers; Veronica J Vieland; Louis G Chicoine; Leif D Nelin
Journal:  Acta Paediatr       Date:  2016-01-11       Impact factor: 2.299

5.  Inhaled nitric oxide applications in paediatric practice.

Authors:  A Bernasconi; M Beghetti
Journal:  Images Paediatr Cardiol       Date:  2002-01

6.  Do alterations in pulmonary vascular tone result in changes in central blood volumes? An experimental study.

Authors:  Jaap Jan Vos; J K Götz Wietasch; Andreas Hoeft; Thomas W L Scheeren
Journal:  Intensive Care Med Exp       Date:  2021-12-17

Review 7.  Halogen exposure injury in the developing lung.

Authors:  Dylan R Addis; Adam Molyvdas; Namasivayam Ambalavanan; Sadis Matalon; Tamas Jilling
Journal:  Ann N Y Acad Sci       Date:  2020-08-01       Impact factor: 6.499

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.